Ballicules.com

Tamoxifen

NOLVADEX

What it isSelective estrogen receptor modulator; hormone receptor-positive breast cancer at any age.

Why this oneIt works before menopause, which aromatase inhibitors do not, and it protects bone in postmenopausal women.

What limits itIt requires CYP2D6 activation to endoxifen, so strong inhibitors such as fluoxetine and paroxetine blunt it. Endometrial cancer and thromboembolism.

FDA-approved for

FDA label

BOXED WARNING For DCIS and high-risk women (risk reduction): serious/life-threatening events — uterine malignancies, stroke, and pulmonary embolism.
FDA dosingPopulationStartTargetMax
Breast cancer (treatment/adjuvant)Adults20 mg QD20 mg QD (20-40 mg/day)40 mg/day (BID if >20 mg)
Ductal carcinoma in situ (DCIS)Adults20 mg QD × 5 yr20 mg QD20 mg QD
Breast cancer risk reduction (high-risk women)Adults20 mg QD × 5 yr20 mg QD20 mg QD

Renal Undefined

Hepatic Undefined

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy Can cause fetal harm (Category D); teratogenic — avoid in pregnancy

Lactation Undefined

⚠ BOXED WARNING

Cost, est. cash$10–$1,000/month

Generic entry2003

Classes and tags

Clinical profile

Therapeutic safety burden2 / 4
Overdose danger2 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades2 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk3 / 4

Legacy pregnancy categoryMultiple / indication-, trimester- or formulation-dependent

Defining liabilityThrombotic, metabolic, hepatic, skeletal or reproductive toxicity varies by hormonal target.

Active metabolites

Mechanism of action: Tamoxifen ballicule

Tamoxifen ballicule: receptor binding, kinetics and half-life diagram

Open Tamoxifen in the interactive console ↗

Memory aids: mascots and interaction avatars

Tamoxifen NOLVADEX mascot mnemonic cartoon
“Tame ox defends Novel Rolodex”
bowling ball → CYP2D6 prodrug
Tamoxifen CYP2D6 substrate avatar
CYP2D6 substrate

Open Tamoxifen in the interactive console ↗